|
Quotes & Info
|
| WHRT > SEC Filings for WHRT > Form 8-K on 20-Aug-2009 | All Recent SEC Filings |
20-Aug-2009
Other Events, Financial Statements and Exhibits
On August 20, 2009, World Heart Corporation issued a press release announcing that it has received FDA conditional approval to begin a bridge-to-transplant (BTT) study of the Levacor™ Ventricular Assist Device (VAD) at ten US centers.
A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
(d) Exhibits.
The following exhibit is being furnished herewith:
Exhibit No. Description of Exhibit.
99.1 Press release, dated August 20, 2009
|
|